Five Leading Pharmaceutical Companies Join Hands with Alibaba Health to Build a New Digital Healthcare Ecosystem

Five Leading Pharmaceutical Companies Join Hands with Alibaba Health to Build a New Digital Healthcare EcosystemOn September 12th, five well-known pharmaceutical companies, including HuiZh China, Qilu Pharmaceutical, Taiji Group, Dain Pharmaceutical, and Jiangzhong Group, gathered in Hangzhou to sign strategic cooperation agreements with Alibaba Health's online pharmacy. This collaboration will focus on multiple areas, including online retail, category expansion, new drug launches, and disease education, to comprehensively implement digital healthcare service cooperation

Five Leading Pharmaceutical Companies Join Hands with Alibaba Health to Build a New Digital Healthcare Ecosystem

On September 12th, five well-known pharmaceutical companies, including HuiZh China, Qilu Pharmaceutical, Taiji Group, Dain Pharmaceutical, and Jiangzhong Group, gathered in Hangzhou to sign strategic cooperation agreements with Alibaba Health's online pharmacy. This collaboration will focus on multiple areas, including online retail, category expansion, new drug launches, and disease education, to comprehensively implement digital healthcare service cooperation. The aim is to establish a more complete pharmaceutical and healthcare service system, enhancing patients' access to medication and improving their health management levels.

HuiZh China will collaborate with Alibaba Health to maximize the utilization rate of its mature original research drugs in the outpatient market, particularly in lower-tier markets. Both parties will jointly establish a patient management platform, leveraging a digital patient service system to expand new chronic disease management models that extend high-value user services. This includes a full-chain cooperation, from channel construction, online launches, disease education, to refined operations, aiming for business growth.

Qilu Pharmaceutical plans to leverage Alibaba Health's massive user base and channel capabilities to achieve efficient coverage of volume-based procurement products in the outpatient market. This will provide users with more diverse drug purchasing channels, improving patient access to medication. Both parties will further deepen digital collaboration for higher-quality coverage of the entire product lifecycle.

Taiji Group, aiming to "build the top brand in traditional Chinese medicine," will collaborate with Alibaba Health to enrich the product portfolio and expand the scope of partnerships, focusing on products like Taiji Huoxiang Zhengqi Oral Solution. Combining their respective R&D strengths and big data capabilities, both parties will jointly develop market-oriented new products, accelerating new product development and meeting diversified market demands.

Dain Pharmaceutical has chosen to combine with Alibaba Health's online medical resources to create an online "service center" for pediatrics. The center will provide professional online pharmaceutical services, offering personalized consultation advice and treatment plans for maternal and infant health and chronic disease management. It will also provide answers for children's medication, disease symptom consultation, health risk assessments, and preventive advice.

Jiangzhong Group has reached an agreement with Alibaba Health to leverage Alibaba Health's digital capabilities, accurately targeting user pain points and better meeting consumer health needs. Both will create personalized digital marketing systems by combining content education and a deep understanding of brand product attributes with the target market.

Zhang Ze, General Manager of Alibaba Health's Self-Operated Business Department and Manager of the Pharmaceutical Platform Business Department, stated that Alibaba Health will restructure its operating system and establish a service system that uses merchandise as the horizontal axis and services as the vertical axis. This will explore new business models and service methods for pharmaceutical companies while providing patients with better treatment, medication, and chronic disease management experiences.

The strategic cooperation of these five leading pharmaceutical companies with Alibaba Health marks a new era in the digital transformation of the pharmaceutical industry. By integrating online and offline resources and harnessing digital technology, pharmaceutical companies can more effectively reach users, provide more precise services, and achieve both business growth and social benefits. In the future, more companies will join this wave of digital healthcare services, jointly promoting high-quality development in the pharmaceutical and healthcare industry.

Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])